Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13058-017-0837-2/MediaObjects/13058_2017_837_Fig2_HTML.gif)
Kaplan-Meier curves for continuation of endocrine therapy among (a) all test-eligible women, (b) by tested status, and (c) by RS category
Kaplan-Meier curves for continuation of endocrine therapy among (a) all test-eligible women, (b) by tested status, and (c) by RS category